Labcorp agrees to acquire select assets of OPKO Health's BioReference Health subsidiary for $722M in cash

Labcorp has agreed to acquire select assets of OPKO Health's BioReference Health subsidiary for $722M in cash, with up to an additional $150M in earnout tied to revenue.

Detected & updated continuously · Source: Nebula